Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 170.50 billion. The enterprise value is 184.95 billion.

Market Cap	170.50B
Enterprise Value	184.95B

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	Mar 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.72%
Shares Change (QoQ)	-1.13%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.88B

Valuation Ratios

The trailing PE ratio is 17.88.

PE Ratio	17.88
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.11, with an EV/FCF ratio of 14.25.

EV / Earnings	19.39
EV / Sales	4.49
EV / EBITDA	11.11
EV / EBIT	14.25
EV / FCF	14.25

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.

Current Ratio	1.04
Quick Ratio	0.79
Debt / Equity	0.71
Debt / EBITDA	1.50
Debt / FCF	1.93
Interest Coverage	16.22

Financial Efficiency

Return on equity (ROE) is 26.28% and return on invested capital (ROIC) is 13.72%.

Return on Equity (ROE)	26.28%
Return on Assets (ROA)	10.09%
Return on Invested Capital (ROIC)	13.72%
Return on Capital Employed (ROCE)	22.19%
Revenue Per Employee	544,443
Profits Per Employee	125,695
Employee Count	75,883
Asset Turnover	0.51
Inventory Turnover	2.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+4.20%
50-Day Moving Average	101.52
200-Day Moving Average	107.62
Relative Strength Index (RSI)	67.69
Average Volume (20 Days)	12,837

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 41.31 billion and earned 9.54 billion in profits. Earnings per share was 4.69.

Revenue	41.31B
Gross Profit	31.08B
Operating Income	13.04B
Pretax Income	10.90B
Net Income	9.54B
EBITDA	16.50B
EBIT	13.04B
Earnings Per Share (EPS)	4.69

Full Income Statement

Balance Sheet

The company has 10.66 billion in cash and 25.08 billion in debt, giving a net cash position of -14.42 billion.

Cash & Cash Equivalents	10.66B
Total Debt	25.08B
Net Cash	-14.42B
Net Cash Per Share	n/a
Equity (Book Value)	35.25B
Book Value Per Share	17.81
Working Capital	808.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.07 billion and capital expenditures -1.09 billion, giving a free cash flow of 12.98 billion.

Operating Cash Flow	14.07B
Capital Expenditures	-1.09B
Free Cash Flow	12.98B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.22%, with operating and profit margins of 31.55% and 23.09%.

Gross Margin	75.22%
Operating Margin	31.55%
Pretax Margin	26.37%
Profit Margin	23.09%
EBITDA Margin	39.95%
EBIT Margin	31.55%
FCF Margin	31.42%

Dividends & Yields

This stock pays an annual dividend of 2.47, which amounts to a dividend yield of 2.32%.

Dividend Per Share	2.47
Dividend Yield	2.32%
Dividend Growth (YoY)	29.66%
Years of Dividend Growth	3
Payout Ratio	63.85%
Buyback Yield	2.72%
Shareholder Yield	5.04%
Earnings Yield	5.59%
FCF Yield	7.61%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.92.

Altman Z-Score	3.92
Piotroski F-Score	n/a